Crescent Capital BDC(CCAP)

Search documents
Crescent Capital BDC(CCAP) - 2023 Q4 - Earnings Call Presentation
2024-02-22 19:33
Since its inception, CCAP has consistently delivered a stable NAV profile $19.90 $20.04 $32.63 $12.59 Q2'15 Q3'15 Q4'15 Q1'16 Q2'16 Q3'16 Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22Q3'22Q4'22Q1'23Q2'23Q3'23Q4'23 NAV Per Share Cumulative Dividends Per Share Note: Past performance does not guarantee or indicate future results. 4 | --- | --- | --- | --- | --- | |-------------|------------------------------------------ ...
Crescent Capital BDC(CCAP) - 2023 Q4 - Earnings Call Transcript
2024-02-22 19:33
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q4 2023 Earnings Conference Call February 22, 2024 12:00 PM ET Company Participants Dan McMahon - Investor Relations Jason Breaux - Chief Executive Officer Gerhard Lombard - Chief Financial Officer Henry Chung - President Conference Call Participants Robert Dodd - Raymond James Paul Johnson - KBW Operator Good afternoon, ladies and gentlemen and welcome to the Crescent Capital BDC, Inc. Fourth Quarter Earnings Conference Call. [Operator Instructions] This call is bei ...
Crescent Capital BDC(CCAP) - 2023 Q4 - Annual Report
2024-02-20 16:00
distributions in the prior year (collectively, the "Excise Tax"). Because we use debt financing, we are subject to (i) an asset coverage ratio requirement under the 27 Certain investors are limited in their ability to make significant investments in us. Private funds that are excluded from the definition of "investment company" either pursuant to Section 3(c)(1) or 3(c)(7) of the 1940 Act are restricted from acquiring directly or through a controlled entity more than 3% of our total outstanding voting stock ...
Crescent Capital BDC(CCAP) - 2023 Q4 - Annual Results
2024-02-20 16:00
| --- | --- | --- | --- | --- | --- | --- | |-----------------------------------------------------------------------------------------------|--------------|--------------------------------------|---------------------------------|---------------------------------------------|----------------------|----------------------| | Investments, at fair value | December \n$ | As of \n 31, 2023 \n1,582.1 | and for the \nSeptember \n$ | three months \n 30, 2023 \n1,564.8 | ended \nDecember \n$ | 31, 2022 \n1,263.0 | | T ...
Crescent Capital BDC (CCAP) Increases Despite Market Slip: Here's What You Need to Know
Zacks Investment Research· 2024-02-13 00:01
Crescent Capital BDC (CCAP) closed the most recent trading day at $16.27, moving +0.93% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 0.1% for the day. Meanwhile, the Dow experienced a rise of 0.33%, and the technology-dominated Nasdaq saw a decrease of 0.3%.Shares of the company have depreciated by 5.12% over the course of the past month, underperforming the Finance sector's gain of 1.98% and the S&P 500's gain of 5.78%.Analysts and investors alike will be ke ...
Crescent Capital BDC (CCAP) Stock Dips While Market Gains: Key Facts
Zacks Investment Research· 2024-02-07 00:01
The most recent trading session ended with Crescent Capital BDC (CCAP) standing at $16.12, reflecting a -0.31% shift from the previouse trading day's closing. This change lagged the S&P 500's 0.23% gain on the day. Elsewhere, the Dow saw an upswing of 0.37%, while the tech-heavy Nasdaq appreciated by 0.07%.The company's stock has dropped by 6.32% in the past month, falling short of the Finance sector's gain of 0.54% and the S&P 500's gain of 5.3%.Investors will be eagerly watching for the performance of Cre ...
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2023 Financial Results
Globenewswire· 2024-01-23 21:15
LOS ANGELES, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2023 on Wednesday, February 21, 2024 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, February 22, 2024 at 12:00 p.m. Eastern Time to discuss its fourth quarter and fiscal year ended December 31, 2023 financial results. Conferen ...
Crescent Capital BDC (CCAP) Stock Sinks As Market Gains: Here's Why
Zacks Investment Research· 2024-01-20 00:21
Crescent Capital BDC (CCAP) closed the most recent trading day at $16.54, moving -0.72% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 1.23%. Elsewhere, the Dow gained 1.06%, while the tech-heavy Nasdaq added 1.7%.Heading into today, shares of the company had lost 5.23% over the past month, lagging the Finance sector's loss of 3.81% and the S&P 500's gain of 0.94% in that time.The investment community will be closely monitoring the performance of Crescent C ...
Crescent Capital BDC(CCAP) - 2023 Q3 - Earnings Call Transcript
2023-11-09 19:13
Crescent Capital BDC Inc. (NASDAQ:CCAP) Q3 2023 Results Conference Call November 9, 2023 12:00 PM ET Company Participants Dan McMahon - VP & Head of Public Investor Relations Jason Breaux - CEO & President Henry Chung - Managing Director Gerhard Lombard - Chief Financial Officer Conference Call Participants Robert Dodd - Raymond James Ryan Lynch - KBW Operator Good afternoon, ladies and gentlemen, and welcome to the Q3 2023 Crescent Capital Inc. Earnings Conference Call. At this time, all lines are in a lis ...
Crescent Capital BDC(CCAP) - 2023 Q3 - Quarterly Report
2023-11-07 16:00
PART I FINANCIAL INFORMATION [Item 1. Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited consolidated financial statements for Crescent Capital BDC, Inc., including statements of assets, operations, changes in net assets, cash flows, and investment schedules [Consolidated Statements of Assets and Liabilities](index=4&type=section&id=Consolidated%20Statements%20of%20Assets%20and%20Liabilities) Total assets increased to $1.62 billion, liabilities grew, and net assets rose to $730.3 million, with NAV per share slightly decreasing Consolidated Balance Sheet Highlights (in thousands) | Metric | Sep 30, 2023 (Unaudited) | Dec 31, 2022 | | :--- | :--- | :--- | | **Assets** | | | | Total Investments, at fair value | $1,564,828 | $1,262,956 | | Total Assets | $1,624,487 | $1,302,878 | | **Liabilities & Net Assets** | | | | Total Debt (net) | $856,656 | $654,456 | | Total Liabilities | $894,221 | $690,337 | | Total Net Assets | $730,266 | $612,541 | | **Net Asset Value Per Share** | **$19.70** | **$19.83** | [Consolidated Statements of Operations](index=5&type=section&id=Consolidated%20Statements%20of%20Operations) Total investment income rose to $134.2 million, driving net investment income to $59.8 million and a $53.0 million net increase in net assets Statement of Operations Summary (in thousands, except per share data) | Metric | Nine Months Ended Sep 30, 2023 | Nine Months Ended Sep 30, 2022 | | :--- | :--- | :--- | | Total Investment Income | $134,176 | $82,142 | | Net Expenses | $73,497 | $38,454 | | Net Investment Income | $59,789 | $43,624 | | Net Realized & Unrealized (Losses) | ($7,540) | ($30,036) | | **Net Increase in Net Assets** | **$52,979** | **$12,942** | | **Net Investment Income Per Share** | **$1.68** | **$1.41** | | **Net Increase in Net Assets Per Share** | **$1.49** | **$0.42** | [Consolidated Statements of Changes in Net Assets](index=7&type=section&id=Consolidated%20Statements%20of%20Changes%20in%20Net%20Assets) Net assets increased by $117.7 million to $730.3 million, primarily from operations and an asset acquisition, partially offset by distributions Reconciliation of Net Assets (Nine Months Ended Sep 30, 2023, in thousands) | Description | Amount | | :--- | :--- | | Balance at Dec 31, 2022 | $612,541 | | Net Increase from Operations | $52,979 | | Issuance for Asset Acquisition | $91,257 | | Deemed Contribution from Adviser | $22,040 | | Distributions from Distributable Earnings | ($48,551) | | **Balance at Sep 30, 2023** | **$730,266** | [Consolidated Statements of Cash Flows](index=9&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) Net cash provided by operating activities was $57.7 million, a reversal from prior year, with $52.0 million used in financing, ending with $22.8 million cash Cash Flow Summary (Nine Months Ended, in thousands) | Cash Flow Activity | Sep 30, 2023 | Sep 30, 2022 | | :--- | :--- | :--- | | Net Cash from Operating Activities | $57,696 | ($13,895) | | Net Cash from Financing Activities | ($52,000) | $12,522 | | Net Increase (Decrease) in Cash | $5,688 | ($1,373) | | **Cash, End of Period** | **$22,755** | **$22,153** | [Consolidated Schedule of Investments](index=10&type=section&id=Consolidated%20Schedule%20of%20Investments) The $1.56 billion investment portfolio is primarily debt-focused, concentrated in Senior Secured First Lien and Unitranche loans, diversified across key industries Portfolio Composition by Investment Type (at Fair Value) | Investment Type | Sep 30, 2023 (%) | Dec 31, 2022 (%) | | :--- | :--- | :--- | | Senior Secured First Lien | 28.4% | 23.8% | | Unitranche First Lien | 60.0% | 65.2% | | Senior Secured Second Lien | 3.7% | 4.8% | | Equity & Other | 6.6% | 4.7% | | Other Debt | 1.3% | 1.5% | Top 5 Industries by Fair Value (Sep 30, 2023) | Industry | Percentage of Fair Value | | :--- | :--- | | Health Care Equipment & Services | 27.4% | | Software & Services | 20.8% | | Commercial & Professional Services | 14.1% | | Consumer Services | 9.5% | | Diversified Financials | 5.2% | - The total fair value of investments increased to **$1.56 billion** as of September 30, 2023, from **$1.26 billion** at the end of 2022[165](index=165&type=chunk) [Notes to Consolidated Financial Statements](index=61&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) This section details accounting policies, investment valuation, related party agreements, outstanding debt, and the recent FCRD acquisition [Note 2. Summary of Significant Accounting Policies](index=63&type=section&id=Note%202.%20Summary%20of%20Significant%20Accounting%20Policies) The company follows ASC 946, fair-valuing illiquid assets through a multi-step process and categorizing investments into a three-level hierarchy - The Board has designated the Adviser as the valuation designee to perform fair value determinations for investments where market quotations are not readily available, following SEC Rule 2a-5[106](index=106&type=chunk) - As of September 30, 2023, the company had sixteen investments across nine portfolio companies on non-accrual status, representing **1.8%** of total debt investments at fair value, an increase from **1.2%** at year-end 2022[117](index=117&type=chunk) [Note 3. Agreements and Related Party Transactions](index=67&type=section&id=Note%203.%20Agreements%20and%20Related%20Party%20Transactions) The company is externally managed by Crescent Cap Advisors, earning base and incentive fees, with the Adviser voluntarily waiving certain fees Management and Incentive Fees (Nine Months Ended Sep 30) | Fee Type (in thousands) | 2023 Incurred | 2023 Waived | 2022 Incurred | 2022 Waived | | :--- | :--- | :--- | :--- | :--- | | Management Fees | $14,541 | ($145) | $12,235 | ($175) | | Income Incentive Fees | $12,634 | ($229) | $8,039 | ($474) | - The Adviser has voluntarily waived income incentive fees to the extent net investment income falls short of the regular declared dividend, a waiver effective through **December 31, 2023**[148](index=148&type=chunk) [Note 6. Debt](index=77&type=section&id=Note%206.%20Debt) Total debt outstanding increased to $864.3 million across various facilities, with the weighted average interest rate on borrowings rising to **6.96%** Debt Composition as of September 30, 2023 (in thousands) | Facility | Drawn Amount | | :--- | :--- | | SPV Asset Facility | $314,750 | | SMBC Corporate Revolving Facility | $252,975 | | Series 2021A Unsecured Notes | $135,000 | | FCRX Unsecured Notes | $111,600 | | Series 2023A Unsecured Notes | $50,000 | | **Total Debt** | **$864,325** | - The combined weighted average interest rate of aggregate borrowings increased to **6.96%** for the nine months ended September 30, 2023, compared to **4.15%** for the same period in 2022[215](index=215&type=chunk) [Note 13. First Eagle Alternative Capital BDC, Inc. Acquisition](index=88&type=section&id=Note%2013.%20First%20Eagle%20Alternative%20Capital%20BDC%2C%20Inc.%20Acquisition) The company completed the acquisition of FCRD on March 9, 2023, accounted for as an asset acquisition with a total purchase price of $129.5 million - The acquisition of FCRD was completed on **March 9, 2023**[266](index=266&type=chunk) FCRD Acquisition Purchase Price (in thousands) | Component | Amount | | :--- | :--- | | Aggregate Share Consideration | $91,257 | | CCAP Cash Consideration | $8,649 | | Deemed contribution from the Adviser | $22,040 | | Transaction costs | $7,565 | | **Total Purchase Price** | **$129,511** | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=89&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses performance, focusing on maximizing total return through debt and equity investments, highlighting increased investment income, portfolio activity, and liquidity [Portfolio and Investment Activity](index=94&type=section&id=Portfolio%20and%20Investment%20Activity) The investment portfolio grew to $1.56 billion, primarily floating-rate debt with an 11.9% yield, with net dispositions during the period Portfolio Statistics | Metric | Sep 30, 2023 | Dec 31, 2022 | | :--- | :--- | :--- | | Weighted avg. yield on income producing securities | 11.9% | 10.8% | | Percentage of debt at floating rate | 98.6% | 98.8% | | Number of portfolio companies | 185 | 129 | - For the nine months ended September 30, 2023, proceeds from investments sold or repaid (**$144.6 million**) exceeded new investments at cost (**$112.2 million**)[316](index=316&type=chunk) - Investments on non-accrual status represented **1.8%** of the portfolio's fair value as of September 30, 2023, compared to **1.2%** as of December 31, 2022[287](index=287&type=chunk) [Results of Operations](index=97&type=section&id=Results%20of%20Operations) Total investment income rose to $134.2 million, while net expenses increased to $74.4 million, resulting in net investment income of $59.8 million - Interest income for the nine months ended Sep 30, 2023, increased to **$123.5 million** from **$75.7 million** in the prior year period, attributed to a rise in benchmark rates, the FCRD Acquisition, and organic portfolio growth[291](index=291&type=chunk) - Interest and other debt financing costs for the nine months ended Sep 30, 2023, increased to **$43.0 million** from **$20.7 million** year-over-year due to higher average debt outstanding and a higher weighted average cost of debt[293](index=293&type=chunk) Net Investment Income Reconciliation (in millions) | Metric | Nine Months Ended Sep 30, 2023 | Nine Months Ended Sep 30, 2022 | | :--- | :--- | :--- | | Total Investment Income | $134.2 | $82.1 | | Total Net Expenses | $74.4 | $38.5 | | **Net Investment Income** | **$59.8** | **$43.6** | [Liquidity and Capital Resources](index=102&type=section&id=Liquidity%20and%20Capital%20Resources) The company had $340.1 million in available liquidity, with total debt of $864.3 million and an asset coverage ratio of 184%, exceeding regulatory requirements - As of September 30, 2023, the company had **$22.8 million** in cash and cash equivalents and **$317.3 million** of undrawn capacity on its credit facilities[328](index=328&type=chunk) - The company's asset coverage ratio was **184%** as of September 30, 2023, in compliance with the **150%** regulatory requirement[362](index=362&type=chunk) - On July 28, 2023, the company repaid its **$50.0 million** 5.95% Series 2020A Unsecured Notes and issued **$50.0 million** of 7.54% Series 2023A Unsecured Notes due 2026[308](index=308&type=chunk)[310](index=310&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=102&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company faces interest rate, valuation, and currency risks, with earnings sensitive to interest rate changes due to **98.6%** variable-rate investments - As of September 30, 2023, **98.6%** of the investments at fair value in the portfolio were at variable rates, making the company's income sensitive to interest rate fluctuations[137](index=137&type=chunk) Annualized Impact of Hypothetical Base Rate Changes (in millions) | Basis Point Change | Net Interest Income Change | | :--- | :--- | | Up 100 basis points | $10.4 | | Up 50 basis points | $5.2 | | Down 50 basis points | ($5.2) | | Down 100 basis points | ($10.4) | - The company uses foreign currency forward contracts to hedge exposure from investments denominated in foreign currencies[344](index=344&type=chunk) [Controls and Procedures](index=103&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and internal control over financial reporting were effective as of September 30, 2023, with no material changes reported - Management concluded that the company's disclosure controls and procedures were effective as of **September 30, 2023**[368](index=368&type=chunk) - There were no changes in internal control over financial reporting during the quarter ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, internal controls[370](index=370&type=chunk) PART II OTHER INFORMATION [Legal Proceedings](index=104&type=section&id=Item%201.%20Legal%20Proceedings) The company is involved in routine lawsuits, which are not anticipated to materially impact its financial condition or results of operations - The company is party to certain lawsuits in the normal course of business but does not expect them to materially affect its business, financial condition, or results of operations[348](index=348&type=chunk) [Risk Factors](index=104&type=section&id=Item%201A.%20Risk%20Factors) This section refers to 10-K risk factors, highlighting systemic risks in the U.S. and global banking sectors, including recent bank failures - The report highlights risks related to the instability of financial institutions, citing the failures of Silicon Valley Bank (SVB) and Signature Bank in **March 2023** as examples that could lead to market-wide problems[139](index=139&type=chunk)[371](index=371&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=105&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The Sun Life purchase program committed to buying up to $20.0 million of common stock, with $10.0 million worth of shares purchased through September 30, 2023 - In connection with the FCRD merger, Sun Life committed to a share purchase program of up to **$20.0 million**. Through September 30, 2023, the program had purchased **629,428 shares** for a total of **$10.0 million**[128](index=128&type=chunk) [Defaults Upon Senior Securities](index=105&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) No defaults upon senior securities were reported during the period - None reported[373](index=373&type=chunk) [Other Information](index=105&type=section&id=Item%205.%20Other%20Information) No director or Section 16 officer adopted or terminated Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during the quarter - During the third quarter of 2023, no director or Section 16 officer adopted or terminated a Rule 10b5-1 trading arrangement[374](index=374&type=chunk) [Exhibits](index=106&type=section&id=Item%206.%20Exhibits) This section lists all exhibits filed with the quarterly report, including corporate governance documents, material contracts, and certifications - The report includes numerous exhibits, such as amendments to the Loan and Security Agreement, various Note Purchase Agreements, and the Senior Secured Revolving Credit Agreement[355](index=355&type=chunk)